CERTAIN INFORMATION HAS BEEN OMITTED FROM THIS DOCUMENT BECAUSE IT IS (I) NOT MATERIAL AND (II) WOULD BE COMPETITIVELY HARMFUL IF PUBLICLY DISCLOSED. OMISSIONS ARE MARKED [*]. SECOND AMENDMENT TO MATERIALS SUPPLIER AGREEMENTMaterials Supplier Agreement • February 24th, 2021 • Insulet Corp • Surgical & medical instruments & apparatus
This Second Amendment to the Materials Supplier Agreement (this “Second Amendment”) is dated as of the 1st day of October 2020 (the “Second Amendment Effective Date”), by and between Insulet Corporation (“Insulet”) and Flextronics Medical Sales and Marketing, Ltd. (the “Supplier”). Insulet and Supplier are referred to herein individually as a “Party” and collectively as the “Parties”.
MATERIALS SUPPLIER AGREEMENT BETWEEN INSULET CORPORATION AND FLEXTRONICS MEDICAL SALES AND MARKETING, LTDMaterials Supplier Agreement • November 4th, 2016 • Insulet Corp • Surgical & medical instruments & apparatus
* Confidential treatment has been requested for portions of this exhibit. The copy filed herewith omits the information subject to the confidentiality request. Omissions are designated as [*]. A complete version of this exhibit has been filed separately with the Securities and Exchange Commission.
MATERIALS SUPPLIER AGREEMENTMaterials Supplier Agreement • May 16th, 2014
The Board of Directors of Vicplas International Ltd (“Company”) would like to announce that its wholly-owned subsidiaries, Forefront Medical Investment Pte. Ltd. and Forefront Medical Technology (Jiangsu) Co., Ltd., have signed a Materials Supplier Agreement (“Agreement”) with Covidien Private Limited and Covidien Healthcare International Trading (Shanghai) Co., Ltd. for contract manufacturing for medical devices.
FIRST AMENDMENT TO MATERIALS SUPPLIER AGREEMENTMaterials Supplier Agreement • August 2nd, 2018 • Insulet Corp • Surgical & medical instruments & apparatus
This First Amendment to the Materials Supplier Agreement (this “Amendment”) is made effective as of January 1, 2018 (the “Amendment Effective Date”), by and between Insulet Corporation, having its place of business at 600 Technology Park Drive, Suite 200, Billerica, Massachusetts 01821 (“Insulet”) and Flextronics Medical Sales and Marketing, Ltd., having its place of business at Level 3, Alexander House 35, Cybercity, Ebene, Mauritius (“Flex”). Insulet and Flex are collectively referred to as the “Parties,” and each a “Party.” The First Amendment and the Original Agreement (as defined below) are collectively referred to herein as the “Agreement.” All capitalized terms used herein are as defined in the Original Agreement, unless otherwise expressly defined herein.
